MRP ₹32329.5
(Inclusive of all Taxes)
₹4849.4 Cashback (15%)
Provide Delivery Location
About Denoci 120 Injection
Denoci 120 Injection belongs to a group of medicines called RANK ligand inhibitors used to treat osteoporosis in postmenopausal women and men who have an increased risk of fracture. Denoci 120 Injection is also used to treat bone loss due to reduced testosterone level caused by surgery, due to the treatment with medicines such as glucocorticoids and in patients with prostate cancer. Denoci 120 Injection may also be used to reduce the risk of fractures in people with multiple myeloma, giant cell tumour of the bone, and to treat high calcium levels caused by cancer.
Denoci 120 Injection contains Denosumab, which works by blocking a receptor in the body that causes bone loss, thereby treating bone loss. Denoci 120 Injection treats giant cell tumour of bone (GCTB) by blocking certain receptors in the tumour cells, thereby slowing the growth of the tumour. Denoci 120 Injection helps treat high calcium levels by decreasing bone breakdown, as a breakdown of the bones releases calcium. Denoci 120 Injection makes the bones stronger and less likely to break.
Denoci 120 Injection will be administered by a healthcare professional; do not self-administer. Sometimes, you may experience common side effects such as bone/joint/muscle pain, arm/leg pain, abdominal discomfort, constipation, and painful/frequent urination. You should talk to your doctor if the side effects persist or worsen.
Denoci 120 Injection might cause jaw osteonecrosis; therefore, maintain good dental hygiene and receive regular dental check-ups whilst on treatment with Denoci 120 Injection . Avoid taking Denoci 120 Injection if you are pregnant. Consult your doctor before taking Denoci 120 Injection if you are breastfeeding. Denoci 120 Injection is not recommended for children below 18 years as safety and effectiveness have not been established. To rule out any interactions, keep your doctor informed about your health condition and medicines.
Uses of Denoci 120 Injection
Denoci 120 Injection used to treat osteoporosis, bone loss, giant cell tumour of the bone, and high calcium levels. The detailed uses of Denoci 120 Injection are as follows:

Have a query?
Directions for Use
Key Benefits
Denoci 120 Injection belongs to a group of medicines called RANK ligand inhibitors used to treat osteoporosis in postmenopausal women and men who have an increased risk of fracture. Denoci 120 Injection is also used to treat bone loss due to reduced hormone levels caused by surgery or due to treatment with medicines in patients with prostate cancer. It is also used to treat bone loss occurring due to long-term treatment with glucocorticoids in patients who are at an increased risk of fractures. Denoci 120 Injection may also be used to reduce the risk of fractures in people with multiple myeloma, giant cell tumours of the bone and to treat high calcium levels caused by cancer. Denoci 120 Injection binds to a protein on RANK ligand on osteoclast (cells that cause bone breakdown) and inhibits their formation, functioning and survival. It decreases bone breakdown, increases bone density, and strengthens the bone. Denoci 120 Injection treats giant cell tumour of bone (GCTB) by blocking certain receptors in the tumour cells, thereby slowing the growth of the tumour. Denoci 120 Injection helps treat high calcium levels by decreasing bone breakdown, as the breakdown of the bones releases calcium. Denoci 120 Injection makes the bones stronger and less likely to break.
How Denoci 120 Injection Works
Storage
What if I have taken an overdose of Denoci 120 Injection
Drug Warnings
Do not take Denoci 120 Injection if you are allergic to any of its components or have hypocalcaemia (low levels of calcium in the blood). Inform your doctor if you have low levels of calcium, kidney dysfunction, liver problems, poor dental health, gum problems, weak immune system, hypoparathyroidism (decreased function of the parathyroid gland), malabsorption, latex allergy, undergone thyroid surgery, planned dental procedure, if you are taking glucocorticoids, or cannot take calcium and vitamin D supplements. Avoid taking Denoci 120 Injection if you are pregnant. Consult your doctor if you are breastfeeding. Denoci 120 Injection is not recommended for children below 18 years as safety and effectiveness have not been established.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
RXDr Reddy's Laboratories Ltd
₹26987.5
(₹14287.53/ 1ml)
RXIntas Pharmaceuticals Ltd
₹29947.5
(₹14445.29/ 1ml)
RXHetero Healthcare Ltd
₹25999
(₹15293.53/ 1ml)
Alcohol
Safe if prescribed
It is not known if alcohol interacts with Denoci 120 Injection , so please consult a doctor.
Pregnancy
Consult your doctor
Denoci 120 Injection is not recommended during pregnancy as it might cause foetal harm. If you are a woman of child-bearing potential, use effective contraception during the treatment with Denoci 120 Injection and for 5 months after discontinuation. Inform your doctor if you are pregnant, think you are pregnant or planning for pregnancy.
Breast Feeding
Consult your doctor
Consult your doctor if you are breastfeeding; your doctor will decide if breastfeeding mothers can take Denoci 120 Injection or not.
Driving
Safe if prescribed
Denoci 120 Injection generally does not affect your ability to drive. However, drive or operate machinery only if you are alert.
Liver
Consult your doctor
Please consult your doctor if you have a liver impairment or any concerns regarding this.
Kidney
Consult your doctor
Please consult your doctor if you have kidney impairment or any concerns regarding this.
Children
Safe if prescribed
Denoci 120 Injection is not recommended for children below 18 years as safety and effectiveness were not established.
Heart
Denoci 120 Injection should be administered with caution in patients with heart problems. Therefore, please talk to your doctor before receiving Denoci 120 Injection .
Geriatrics
Consult your doctor
Denoci 120 Injection should be administered with caution in older adults. Always seek medical advice before receiving it.
Denoci 120 Injection is used to treat osteoporosis in postmenopausal women and men who have an increased risk of fracture. It is also used to treat bone loss and reduce the risk of fractures.
Denoci 120 Injection binds to a protein on RANK ligand on osteoclast (cells that cause bone breakdown) and inhibits their formation, functioning and survival. Thereby decreases bone breakdown, increases bone density, and strengthens the bone. Denoci 120 Injection makes the bones stronger and less likely to break.
Osteonecrosis of the jaw (bone damage in the jaw) might be a side-effect of Denoci 120 Injection . The risk increases in people taking Denoci 120 Injection for longer durations. It might also occur upon discontinuation of the treatment. Maintain good dental hygiene and receive regular dental check-ups whilst on treatment with Denoci 120 Injection . Inform your doctor if you have dental problems, gum disease, planned tooth extractions, cancer, if you smoke, or are taking bisphosphonates or corticosteroids.
Breakdown of bones releases calcium and causes hypercalcemia (high calcium levels in the blood). Denoci 120 Injection helps treat high calcium levels by decreasing bone breakdown.
Unusual thigh bone fractures might occur whilst on treatment with Denoci 120 Injection . Consult your doctor if you experience new or unusual pain in the thigh, hip, or groin.
Denoci 120 Injection treats giant cell tumour of bone (GCTB) by blocking certain receptors in the tumour cells, thereby slows the tumour growth. Giant cell tumour of the bone is a non-cancerous tumour that typically grows at the ends of long bones.
Denoci 120 Injection might cause skin infections. Consult your doctor immediately if you notice symptoms such as swollen skin, redness, cellulitis (hot and tender skin), commonly in the lower leg with feverish symptoms.
Denoci 120 Injection has been used safely for up to 8 years, showing substantial increases in bone density during that time. However, the optimal duration of therapy varies depending on individual health conditions and needs. Long-term use should be closely monitored by your healthcare provider to assess benefits, risks, and the need for continued therapy. Always consult the doctor for personalized guidance.
Some people may experience hair loss while using Denoci 120 Injection . However, individual reactions to medications can vary. If you experience hair loss or any unusual symptoms while taking Denoci 120 Injection , consult the doctor to determine the cause and discuss appropriate management options.
No, Denoci 120 Injection is not a chemotherapy medication. It is a monoclonal antibody which is used to treat conditions like osteoporosis, and bone loss associated with certain cancers, and to prevent bone fractures in patients with metastatic bone disease. It targets a protein called RANKL to inhibit bone breakdown, thereby increasing bone strength and density.
Denoci 120 Injection is administered subcutaneously (under the skin) in your upper arm, upper thigh, or stomach area by the doctor or nurse, usually given once every 6 months for osteoporosis. Your doctor will determine the exact schedule based on your condition. Always follow the doctor's instructions regarding dosage and scheduling, as it may vary based on your specific medical condition.
You should inform your doctor before receiving Denoci 120 Injection , as it is not recommended during pregnancy due to the potential risk of harm to the foetus.
Denoci 120 Injection should be stored in a refrigerator at a temperature between 2°C and 8°C. Do not freeze it. Keep the vial in its outer carton to protect it from light.
The side effects of Denoci 120 Injection include abdominal discomfort, bone/joint/muscle pain, arm/leg pain, constipation, and painful/frequent urination. Consult the doctor if any of these side effects persist or worsen.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.
We provide you with authentic, trustworthy and relevant information